HomeCompareIOBCF vs MAIN

IOBCF vs MAIN: Dividend Comparison 2026

IOBCF yields 1.84% · MAIN yields 7.09%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MAIN wins by $2.60M in total portfolio value
10 years
IOBCF
IOBCF
● Live price
1.84%
Share price
$15.00
Annual div
$0.28
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$45.35M
Annual income
$41,068,608.41
Full IOBCF calculator →
MAIN
Main Street Capital Corporation
● Live price
7.09%
Share price
$51.65
Annual div
$3.66
5Y div CAGR
72.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47.95M
Annual income
$40,208,699.11
Full MAIN calculator →

Portfolio growth — IOBCF vs MAIN

📍 MAIN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIOBCFMAIN
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IOBCF + MAIN cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
IOBCF pays
MAIN pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IOBCF
Annual income on $10K today (after 15% tax)
$156.68/yr
After 10yr DRIP, annual income (after tax)
$34,908,317.15/yr
MAIN
Annual income on $10K today (after 15% tax)
$602.32/yr
After 10yr DRIP, annual income (after tax)
$34,177,394.24/yr
At 15% tax rate, IOBCF beats the other by $730,922.90/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IOBCF + MAIN for your $10,000?

IOBCF: 50%MAIN: 50%
100% MAIN50/50100% IOBCF
Portfolio after 10yr
$46.65M
Annual income
$40,638,653.77/yr
Blended yield
87.12%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MAIN right now

IOBCF
No analyst data
Altman Z
2.4
Piotroski
4/9
MAIN
Analyst Ratings
2
Buy
11
Hold
Consensus: Hold
Price Target
$65.25
+26.3% upside vs current
Range: $60.00 — $70.00
Altman Z
1.7
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IOBCF buys
0
MAIN buys
0
No recent congressional trades found for IOBCF or MAIN in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIOBCFMAIN
Forward yield1.84%7.09%
Annual dividend / share$0.28$3.66
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%72.7%
Portfolio after 10y$45.35M$47.95M
Annual income after 10y$41,068,608.41$40,208,699.11
Total dividends collected$44.99M$46.82M
Payment frequencyquarterlymonthly
SectorStockBDC

Year-by-year: IOBCF vs MAIN ($10,000, DRIP)

YearIOBCF PortfolioIOBCF Income/yrMAIN PortfolioMAIN Income/yrGap
1← crossover$11,069$368.67$12,464$1,223.78$1.4KMAIN
2$12,606$762.74$16,353$2,343.58$3.7KMAIN
3$15,112$1,623.72$23,105$4,724.42$8.0KMAIN
4$19,809$3,638.35$36,226$10,256.23$16.4KMAIN
5$30,109$8,913.99$65,426$24,707.64$35.3KMAIN
6$57,543$25,325.84$142,101$68,562.02$84.6KMAIN
7$152,040$90,469.27$388,521$228,799.95$236.5KMAIN
8$609,485$446,801.92$1,397,868$961,169.80$788.4KMAIN
9$4,000,001$3,347,852.94$6,884,663$5,313,459.69$2.88MMAIN
10$45,348,610$41,068,608.41$47,947,060$40,208,699.11$2.60MMAIN

IOBCF vs MAIN: Complete Analysis 2026

IOBCFStock

Ion Beam Applications SA develops, manufactures, and supports medical devices and software solutions for cancer treatments in Belgium, the United States, and internationally. The company operates through Proton Therapy and Other Accelerators, and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems. This segment also offers turnkey solutions for the treatment of cancer through the use of proton beams; and a line of cyclotrons used for the production of positron emission tomography or SPECT radioisotopes, as well as a line of industrial accelerators for sterilization and ionization. The Dosimetry segment provides solutions and services that enhances efficiency and minimizes errors in radiation therapy and medical imaging quality assurance and calibration procedures. The company has strategic research and development partnership with SCK CEN (Belgian nuclear research center) to enable the production of Actinimum-225 (225Ac), a novel radioisotope for the treatment of cancer; and an agreement with University of Pennsylvania for advance research in ConformalFLASH. Ion Beam Applications SA was incorporated in 1986 and is headquartered in Louvain-la-Neuve, Belgium.

Full IOBCF Calculator →

MAINBDC

Main Street Capital Corporation is a business development company specializes in equity capital to lower middle market companies. The firm specializing in recapitalizations, management buyouts, refinancing, family estate planning, management buyouts, refinancing, industry consolidation, mature, later stage emerging growth. The firm also provides debt capital to middle market companies for acquisitions, management buyouts, growth financings, recapitalizations and refinancing. The firm seeks to partner with entrepreneurs, business owners and management teams and generally provides one stop financing alternatives within its lower middle market portfolio. It prefers to invest in air freight and logistics, auto components, building products, chemicals, commercial services, computers, construction and engineering, consumer finance, consumer services, electronic equipment, energy equipment and services, financial services, health care equipment, health care providers, hotels, restaurants, and leisure, internet software and services, IT Services, machinery, oil, gas and consumable fuels, paper and forest products, professional and industrial services, road and rail, software, specialty retail, telecommunication, consumer discretionary, energy, materials, technology, and transportation. The firm typically invests in lower middle market companies generally with annual revenues between $5 million and $300 million. It prefers to invest in ranging between $2 million and $75 million in equity investment and enterprise value in ranging between $3 million and $20 million. The firm typically prefers to invest in the range of $5 million and $50 million per transaction in debt investment value and in the range of $1 million and $20 million in annual EBITDA. The firm's middle market debt investments are made in businesses that are generally larger in size than its lower middle market portfolio companies. It takes 5 percent minority and up to 50 percent majority equity investments. Main Street Capital Corporation was founded in 2007 and is based in Houston, Texas with an additional office in Chojnów, Poland.

Full MAIN Calculator →
📬

Get this IOBCF vs MAIN comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IOBCF vs SCHDIOBCF vs JEPIIOBCF vs OIOBCF vs KOIOBCF vs ARCCIOBCF vs HTGCIOBCF vs GBDCIOBCF vs ORCC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.